Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

3.290 -0.080 (-2.37%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Here's What Investors Liked About Bionano Genomics' Q1 Results
The company delivered a pleasant surprise. 
Via The Motley Fool
Bionano Genomics, Inc (BNGO) Q1 2021 Earnings Call Transcript
BNGO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
13 Stocks Moving In Thursday's After-Hours Session
Gainers DoorDash (NYSE: DASH) shares are trading higher after the company reported better-than-expected Q1 sales results. Bionano Genomics (NASDAQ: BNGO) shares are trading higher... 
Via Benzinga
Why BioNano Genomics Traded Higher Today
BioNano Genomics Inc (NASDAQ:BNGO) shares traded higher by... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Bionano Genomics (NASDAQ:BNGO) st... 
Via Benzinga
Is Reddit Favorite BioNano Genomics About To Nosedive?
BioNano Genomics (NASDAQ:BNGO) is testing an important sup... 
Via Benzinga
What's Going On With Bionano Genomics Stock Today?
BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Mon... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Is Bionano Genomics a Buy Ahead of Earnings?
Don’t mistake Bionano for just any Reddit stock. With its Q1 earnings looming, BNGO stock is attractively priced near its 2021 low. 
Via InvestorPlace
Don’t Look Now, but Bionano Genomics May Be a Buy
Bionano Genomics lost a lot of supporters in recent months and some never came to the rescue, but a lifeline has been thrown to BNGO stock. 
Via InvestorPlace
Don’t Confuse Bionano Genomics As an Investment Right Now
The science underlining BNGO stock is incredibly compelling. But that’s not what the market actually cares about right now. 
Via InvestorPlace
Bionano Genomics Has Disappointed, but Its NHS Deal May Turn Things Around
It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
Why Cyclerion, Sol-Gel, Aldeyra, DermTech and Bionano Genomics Are Moving Today
Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
Bionano’s UK Deal Is Huge for BNGO Stock
Bionano's deal with the UK's National Health Service validates the company's Saphyr system and puts it on the road to becoming a global powerhouse 
Via InvestorPlace
Is Bionano Genomics a Buy?
Can you count on this company's novel gene diagnostic technology? 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0... 
Via Benzinga
Topics Artificial Intelligence
20 Stocks Moving in Thursday's Pre-Market Session
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:... 
Via Benzinga
2 Biopharma Stocks That Look Ready For A Bullish Reversal
Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced... 
Via Benzinga
Why Bionano Genomics, Ocugen Are Rallying Today
Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U.... 
Via Benzinga
Should You Buy Bionano Genomics in April?
This stock market mover's growth story is just beginning. 
Via The Motley Fool
Why Bionano Genomics Stock Is Tumbling Today
No news; just run-of-the-mill volatility. 
Via The Motley Fool
Bionano Genomics Stock Is Too Wild for Its Own Good
BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment. 
Via InvestorPlace
Bionano Genomics Stock Has Huge Potential, But It’s Very Risky
BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.